Heartburn without oesophagitis: Efficacy of omeprazole therapy and features determining therapeutic response

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 10, 1997, Pages 974-979

  Lind, T ^b   Havelund, T ^a   Carlsson, R ^b   Anker Hansen, O ^b   Glise, H ^b   Hernqvist, H ^b   Junghard, O ^b   Lauritsen, K ^b   Lundell, L ^b   Pedersen, S A ^b   Stubberod A ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Endoscopy negative; Gastro oesophageal reflux; Heartburn; Omeprazole; pH monitoring; Placebo

Indexed keywords

OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS PH; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 15444356140     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709011212     Document Type: Article

References (29)

1. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51 Suppl 1:24-9.
2. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989;24 Suppl 156:7-13.
3. Jones RH, Hungin APS, Phillips J, Mills JG. Gastro-oesophageal reflux disease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1995;1:149-54.
4. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life measurements for use in upper gastrointestinal disease. Scand J Gastroenterol 1996;31 Suppl 221:8-13.
5. Hetzel DJ, Dent J, Reed WD, Firoze M, Narielvala FM, Mackinnon M, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
6. Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, et al. Omeprazole and ranitidine in the treatment of reflux oesophagitis. Br Med J 1988;296:89-92.
7. Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts JL. Omeprazole (40 mg) is superior to ranitidine in the short term treatment of ulcerated reflux esophagitis. Dig Dis Sci 1988;3: 523-9.
8. Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results from a double-blind, randomized, multicentre study. Scand J Gastroenterol 1988;23:625-32.
9. Zeitoun P, Rampal P, Barbier P, Isal J-P, Eriksson S, Carlsson R. Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.i.d.) in reflux esophagitis. Results of a double-blind, randomized trial. Gastroenterol Clin Biol 1989;13:457-62.
10. Bate CM, Crowe JP, Dickinson RJ, Green JRB, Banerjee S, Dronfield MW, et al. Reflux oesophagitis resolves more rapidly with omeprazole 20 mg once daily than with ranitidine 150 mg twice daily: omeprazole 40 mg once daily provides further benefit in unresponsive patients. Br J Clin Res 1991;2:133-48.
11. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. multicenter study. Gastroenterology 1992;102:109-18.
12. Dent J, Yeomans N, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ, et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double-blind trial of their efficacy and safety. Gut 1994;35:590-8.
13. Hallerbäck B, Unge P, Carling L, Edwin B, Glise H, Havu N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994;107:1305-11.
14. Bate CM, Booth SN, Crowe JP, Mountford RA, Keeling PWN, Hepworth-Jones B, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of oesophagitis. Gut 1995;36:492-8.
15. Schindlbeck NE, Klauser AG, Berghammer G, Londong W, Müller-Lissner SA. Three year follow up of patients with gastroesophageal reflux disease. Gut 1992;33:1016-9.
16. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205-8.
17. Johnsson F, Joelsson B, Gudmunsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroeneterol 1987;22:714-8.
18. Johansson KE, Ask P, Boeryd B, Fransson SG, Tibbling L. Oesophagitis, signs of reflux and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Scand J Gastroenterol 1986;21:837-47.
19. Joelsson B, Johnsson F. Heartburn - the acid test. Gut 1989;30: 1523-5.
20. Masclee AAM, de Best ACAM, de Graaf R, Cluysenaer OJJ, Jansen JBMJ. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990;25:225-30.
21. Galmiche J-P, Janssens J. The pathophysiology of gastro-oesophageal reflux disease: an overview. Scand J Gastroenterol 1995;30 Suppl 211:7-18.
22. Johnston BT, Lewis SA, Collins JSA, McFarland RJ, Love AHG. Acid perception in gastroesophageal reflux disease is dependent on psychosocial factors. Scand J Gastroenterol 1995; 30:1-5.
23. Bytzer P, Havelund T, Møller Hansen J. Interobserver variation in the endoscopic diagnosis of reflux esophagitis. Scand J Gastroenterol 1993;28:119-25.
24. Armstrong D, Monnier P, Nicolet M, Blum AL, Savary M. Endoscopic assessment of oesophagitis. Gullet 1991;1:63-7.
25. Wiener GJ, Richter JE, Cooper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988; 83:358-61.
26. Merki HS, Witzel L, Walt RP, Cohnen E, Harre K, Heim J, et al. Day-to-day variation of 24-hour intragastric acidity. Gastroenterology 1988;94:887-91.
27. Murphy DW, Yuan Y, Castell DO. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci 1989;34:649-56.
28. Shi G, Bruley des Varannes S, Scarpignato C, Le Ruhn M, Galmiche J-P. Reflux related symptoms in patients with normal esophageal exposure to acid. Gut 1995;37:457-64.
29. Trimble KC, Pryde A, Heading RC. Lowered esophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GERD. Gut 1995;37:7-12.